Celestica (NYSE:CLS) Trading Down 8.7% – Should You Sell?

Celestica, Inc. (NYSE:CLS) (TSE:CLS)’s share price dropped 8.7% during trading on Monday . The stock traded as low as $313.00 and last traded at $316.3420. 2,327,435 shares traded hands during trading, a decline of 5% from the average session volume of 2,441,861 shares. The stock had previously closed at $346.55.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. FBN Securities started coverage on shares of Celestica in a research note on Tuesday. They issued an “outperform” rating and a $375.00 price objective for the company. Zacks Research raised shares of Celestica from a “hold” rating to a “strong-buy” rating in a research note on Friday, June 26th. Barclays cut their price objective on shares of Celestica from $430.00 to $406.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. Stifel Nicolaus set a $500.00 target price on Celestica in a research report on Tuesday, July 28th. Finally, Scotiabank assumed coverage on Celestica in a report on Tuesday, August 11th. They issued a “sector outperform” rating and a $500.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Celestica presently has an average rating of “Buy” and a consensus price target of $436.86.

Celestica Stock Performance

The company has a 50-day moving average of $324.30 and a 200-day moving average of $337.78. The company has a market cap of $36.39 billion, a PE ratio of 32.90 and a beta of 2.04. The company has a quick ratio of 0.68, a current ratio of 1.23 and a debt-to-equity ratio of 0.32.

Celestica (NYSE:CLS) (TSE:CLS) last posted its quarterly earnings data on Monday, July 27th. The technology company reported $2.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.29 by $0.25. Celestica had a net margin of 7.16% and a return on equity of 39.96%. The firm had revenue of $4.68 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same period in the previous year, the firm earned $1.39 EPS. The business’s revenue for the quarter was up 62.4% compared to the same quarter last year. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, analysts anticipate that Celestica, Inc. will post 10.71 earnings per share for the current year.

Insider Activity at Celestica

In related news, CFO Mandeep Chawla sold 16,117 shares of Celestica stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $369.32, for a total transaction of $5,952,330.44. Following the sale, the chief financial officer directly owned 65,444 shares in the company, valued at approximately $24,169,778.08. This trade represents a 19.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Robert Mionis sold 98,453 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total value of $36,328,172.47. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 199,553 shares of company stock worth $73,437,196. Insiders own 1.10% of the company’s stock.

Institutional Trading of Celestica

Several hedge funds have recently added to or reduced their stakes in CLS. Cibc World Market Inc. purchased a new stake in Celestica during the second quarter valued at about $757,811,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Celestica in the second quarter worth about $674,199,000. Norges Bank bought a new stake in shares of Celestica in the fourth quarter valued at approximately $456,511,000. Bank of America Corp DE bought a new stake in shares of Celestica in the second quarter valued at approximately $444,899,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in shares of Celestica during the 2nd quarter valued at approximately $351,717,000. Institutional investors own 67.38% of the company’s stock.

About Celestica

Celestica Inc (NYSE: CLS) is a global provider of design, manufacturing, and supply chain solutions for technology companies and other businesses. The company helps customers develop, manufacture, and support complex electronic products and systems, offering services that span product design and engineering, prototyping, printed circuit board assembly, systems integration, testing, supply chain management, and after-market support.

Celestica serves customers across several markets, including communications and cloud infrastructure, aerospace and defense, industrial technology, health technology, and capital equipment.